Integration breakthrough enables vocal biomarker health tracking in small-footprint chipsets for hearing aids, earbuds, headphones, and other wearables
BOSTON--(BUSINESS WIRE)--#CognitiveHealth--As consumer intrigue and demand for accessible health wearables grows, the convergence of voice artificial intelligence (AI) and proactive health tools is setting the standard for personalized care. Leading the trend is Sonde Health, which has now integrated its voice-based health monitoring technology into Qualcomm's Snapdragon S7+ Gen 1 Sound Platform.
Building on its longtime partnership with Qualcomm, Sonde has optimized its technology to operate within the strict power and processing constraints of edge devices while maintaining its industry-leading accuracy. This development enables manufacturers to incorporate Sonde's voice-based mental and cognitive fitness monitoring capabilities directly into next-generation audio devices like those powered by Qualcomm Technology Inc.'s compact chipset.
"By successfully embedding our technology directly into small-footprint chipsets, we've turned everyday audio devices into high-powered health tracking wearables," said David Liu, CEO of Sonde Health. "We have proven that even the smallest consumer wearables and devices such as hearing aids, earbuds, headphones, and even smart glasses can track cognitive and mental fitness, fundamentally changing how people will manage their well-being."
Beyond Snapdragon S7+ Gen 1, Sonde has also optimized its technology for the QCC5181 and SM8450 families of Qualcomm processors and is designed to be seamlessly ported to other front-end voice processors and sub-processors.
Sonde's vocal biomarker technology enables real-time, non-invasive monitoring of mental fitness (e.g., depression, anxiety) and cognitive fitness (e.g., cognitive load, mild cognitive impairment) using just a short 30-second voice sample. Embedding this technology directly into Snapdragon's S7 and S7+ chipsets makes it possible for manufacturers to seamlessly integrate advanced health diagnostics into their devices without requiring any hardware changes.
Other key features and benefits include:
- Optimized software development kit (SDK) for OEMs: Reduces integration time, enabling manufacturers to add Sonde's technology to their devices in just a few weeks, accelerating time-to-market.
- Edge AI capabilities: On-device processing ensures real-time analysis and reduced latency, as no audio data is stored on the device or sent to the cloud.
- Enhanced user experience: Consumers can monitor their mental and cognitive fitness using only their voice, turning their everyday devices into powerful health trackers.
- High user engagement: Health screening in the background on edge devices overcomes user engagement challenges found in most health care and wellness devices.
- Security and privacy: Processing audio data locally on the device ensures that user data is kept secure and confidential.
For more information about integrating Sonde's vocal biomarker platform into consumer devices or applications, visit .
About Sonde Health
Sonde Health is the global leader in voice-based health tracking and data insights. Sonde's vocal biomarker API/SDK serves enterprise apps and devices spanning consumer wellness to population health. Leveraging a best-in-class voice data set and clinical research with over 1.2 million samples from 85,000+ individuals on four continents, Sonde uses advanced audio signal processing, speech science, and AI/machine learning to sense and analyze subtle vocal changes due to changes in a person's physiology to provide key insights into health and well-being.
Contacts
Media Contact
Denise DiMeglio
Gregory FCA, for Sonde Health
denise@gregoryfca.com
610-228-2102
